Abstract:During the first outbreak of severe acute respiratory syndrome (SARS) in early 2003, almost 8500 people worldwide were diagnosed with the disease, and approximately 800 died of it. The epidemic was contained by July, 2003, but since then, the disease has re-emerged in the Guangdong province in Southern China around the turn of the year 2003, although the number of cases was very limited this time. In addition, there were two cases of SARS caused by improper sample handling in research laboratories in Singapore and Taiwan. A “mini-outbreak” originated from several independent laboratory infections at a research laboratory in Beijing in March and April, 2004, and led to infection chains encompassing three generations.This time, China escaped another epidemic since fortunately, the number of diseased people was limited to nine, although there was one fatality. In any case, these isolated mini-outbreaks remind us of the global threat that SARS still represents. In late March, 2003, a new coronavirus, SARS-CoV, was isolated from affected tissue of SARS patients and identified as the cause of the disease [1, 2]. Coronaviridae are RNA viruses that have been united with the families Arteriviridae and Roniviridae in the order Nidovirales. The phylogenetic relationship of these morphologically unrelated virus families is based on their similar polycistronic genome organization, common transcriptional and post-translational strategies, and a conserved array of homologous domains in the viral polyproteins [3–5]. Coronaviruses are responsible for a number of diseases of man and animals, some of which have major economical impacts, although the human coronaviruses have clearly been neglected before SARS emerged. Transmissible gastroenteritis virus (TGEV) infection is associated with severe and often fatal diarrhoea in young pigs [6, 7]. The human coronaviruses (HCoV) 229E and OC43 are major causes Coronavirus main proteinase: target for antiviral drug therapy

The Genome and Encoded Proteins of Coronavirus

Genome organization of the SARS-CoV.

A Complete Sequence and Comparative Analysis of a SARS-associated Virus (isolate BJ01).

[Genomic Characterization of SARS Coronavirus: a Novel Member of Coronavirus].

Characterization of Viral Proteins Encoded by the SARS-coronavirus Genome

Bioinformatics research on the SARS coronavirus (SARS_CoV) in China.

Towards our understanding of SARS-CoV, an emerging and devastating but quickly conquered virus.

Coronavirus, the King Who Wanted More Than a Crown: From Common to the Highly Pathogenic SARS-CoV-2, Is the Key in the Accessory Genes?

Evolution and Variation of the SARS-CoV Genome

A Crowned Killer’s Résumé: Genome, Structure, Receptors, and Origin of SARS-CoV-2

[The Genome Comparison of SARS-CoV and Other Coronaviruses].

Coronavirus Main Proteinase: Target for Antiviral Drug Therapy

Genetic Evolution Analysis of 2019 Novel Coronavirus and Coronavirus from Other Species.

Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan

Genomic Characterization And Infectivity Of A Novel Sars-Like Coronavirus In Chinese Bats

Genomic Feature Analysis of Betacoronavirus Provides Insights Into SARS and COVID-19 Pandemics

Molecular Evolution of the Sars Coronavirus During the Course of the Sars Epidemic in China

Bioinformatic Analysis of Putative Gene Products Encoded in SARS-HCoV Genome

Protein Subcellular Localization Prediction and Genomic Polymorphism Analysis of the SARS Coronavirus

Isolation of virus from a SARS patient and genome-wide analysis of genetic mutations related to pathogenesis and epidemiology from 47 SARS-CoV isolates

Global genomic diversity and conservation of SARS-CoV-2 since the COVID-19 outbreak